Delivery Order SPE2DB22D1202-SPE2DB25FVDV0
Award Date 7/2/25
Potential Completion Date 7/24/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $7,163.24 and a period of performance through June 13, 2025. The contract is not set aside for any special program. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $10,744.80. The contract is a firm fixed-price delivery order, with a period of performance through May 29, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,205.58, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML medical products. It is a firm fixed price contract with a completion date of July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a firm fixed price, has no set-aside designation, and has a ceiling value of $32,264.46. The period of performance extends to June 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a ceiling value of $17,908.00. The contract is a firm fixed-price delivery order with a completion date of July 30, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,783.50 firm fixed-price contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product used for infectious disease prevention and treatment. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product, with a total ceiling value of $2,205.58 and a period of performance through July 22, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price of $10,744.80 and a completion date of June 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specialty pharmaceutical product, with a ceiling value of $11,659.62 and a period of performance through December 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...